Clinical trial / 1979
High-dose vitamin C therapy did not improve symptoms, performance status, weight, or survival in patients with advanced cancer.
A controlled double-blind study evaluated the effects of high-dose vitamin C (10 g per day) compared to a flavored lactose placebo in 150 patients with advanced cancer. Among evaluable patients (60 receiving vitamin C and 63 placebo), no appreciable differences were found in changes in symptoms, performance status, appetite, or weight. The median survival for all patients was about seven weeks, with essentially overlapping survival curves, showing no therapeutic benefit from vitamin C in this cohort.
- Study type
- Double-blind randomized controlled trial
- Who was studied
- 150 patients with advanced cancer (60 evaluable on vitamin C, 63 on placebo)
- What was measured
- Symptoms, performance status, appetite, weight, and survival
THE PAPER
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.
Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S. N Engl J Med, 1979.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.